DermTech, Inc.
DMTK · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $24 | $60 | $49 | $83 |
| - Cash | $28 | $37 | $37 | $43 |
| + Debt | $54 | $54 | $55 | $55 |
| Enterprise Value | $50 | $78 | $67 | $95 |
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | -2% | 0.2% | -1.6% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 18.5% | 11.2% | 4.4% | 0.2% |
| EBITDA | -$19 | -$17 | -$18 | -$31 |
| % Margin | -496.8% | -432.5% | -471.7% | -770.3% |
| Net Income | -$20 | -$19 | -$19 | -$31 |
| % Margin | -520.4% | -486.5% | -489.5% | -788% |
| EPS Diluted | -0.58 | -0.56 | -0.57 | -0.99 |
| % Growth | -3.6% | 1.8% | 42.4% | – |
| Operating Cash Flow | -$17 | -$13 | -$19 | -$23 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$17 | -$13 | -$19 | -$23 |